Published online by Cambridge University Press: 24 December 2009
Introduction
Primary infection caused by varicella-zoster virus (VZV) is manifest by varicella (chickenpox), while reactivation of latent virus causes herpes zoster (shingles). In immunocompetent children, varicella is usually not a serious disease, but can cause severe morbidity and mortality in adults and in immunocompromised individuals. Similarly, herpes zoster is associated with much greater morbidity in patients with impaired cell-mediated immune responses. In addition, herpes zoster can cause prolonged pain (postherpetic neuralgia) that can be very difficult to manage, particularly in older individuals. The outcomes of varicella and herpes zoster, especially in immunocompromised patients, have been dramatically improved by the development of safe and effective antiviral drugs with potent activity against VZV. Early drugs with modest efficacy and substantial toxicity (e.g., interferon, vidarabine, etc.) have been replaced by antiviral agents with enhanced in vitro activity, improved pharmacokinetic properties, and excellent safety profiles.
Diagnosis
Most experienced physicians will be able to make an accurate clinical diagnosis of chickenpox based on the distinctive appearance of the skin lesions (Fig. 65.1(a)). The clinical syndrome of a child with mild constitutional symptoms, the typical diffuse vesicular rash, and no prior history of chickenpox is strongly suggestive of the diagnosis, especially if there has been exposure to VZV within the previous two weeks. However, in countries where the incidence of varicella is dramatically declining (such as the United States), younger physicians will have fewer opportunities to see patients with chickenpox and may feel less confident with the clinical diagnosis.
To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.